Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01059786
Brief Title: Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

First Submitted : January 29, 2010
First Submitted that Met QC Criteria : January 29, 2010
First Posted : February 1, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : December 7, 2018
Last Update Posted : December 10, 2018